New molecular targets for the treatment of neovascular age-related macular degeneration
Submitted: 26 May 2017
Accepted: 3 November 2017
Published: 27 November 2017
Accepted: 3 November 2017
Abstract Views: 1324
PDF: 459
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Tosi, G. M., Barbarino, M., Orlandini, M., & Galvagni, F. (2017). New molecular targets for the treatment of neovascular age-related macular degeneration. Translational Medicine Reports, 2(1). https://doi.org/10.4081/tmr.6819
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.